about
Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acidHistone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in miceA novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcriptionNucleosome Dancing at the Tempo of Histone Tail AcetylationFunctional O-GlcNAc modifications: implications in molecular regulation and pathophysiologyTargeted histone acetylation at the yeast CUP1 promoter requires the transcriptional activator, the TATA boxes, and the putative histone acetylase encoded by SPT10.A role for mammalian Sin3 in permanent gene silencingThe role of epigenetic mechanisms and processes in autoimmune disordersInhibition of N-terminal lysines acetylation and transcription factor assembly by epirubicin induced deranged cell homeostasisDepletion of cellular iron by curcumin leads to alteration in histone acetylation and degradation of Sml1p in Saccharomyces cerevisiaeTargeting Lysine Deacetylases (KDACs) in ParasitesExploration of Novel Inhibitors for Class I Histone Deacetylase Isoforms by QSAR Modeling and Molecular Dynamics Simulation AssaysCancer biology: mechanism of antitumour action of vorinostat (suberoylanilide hydroxamic acid), a novel histone deacetylase inhibitorModulation of ISWI function by site-specific histone acetylation.The elongata mutants identify a functional Elongator complex in plants with a role in cell proliferation during organ growth.Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas.Transcription factor NF-kappaB differentially regulates death receptor 5 expression involving histone deacetylase 1.Epigenetic Signatures in Breast Cancer: Clinical PerspectiveSorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cells.Acetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation.Histone modification enzymes: novel targets for cancer drugs.Interactive roles of Ets-1, Sp1, and acetylated histones in the retinoic acid-dependent activation of guanylyl cyclase/atrial natriuretic peptide receptor-A gene transcription.Role of histone deacetylases in gene regulation at nuclear lamina.Structural and functional compartmentalization of the cell nucleus in supraoptic neurons.Lung cancer therapeutics that target signaling pathways: an update.Selective HDAC1/HDAC2 inhibitors induce neuroblastoma differentiation.Nucleosome sliding: facts and fictionThe epigenetics of autoimmunity.PAX5 activates the transcription of the human telomerase reverse transcriptase gene in B cells.Histone deacetylase inhibitors: from target to clinical trials.Histone deacetylase inhibitors in clinical development.Small cell lung cancer: will recent progress lead to improved outcomes?Epigenetics and autoimmune diseases.Novel therapeutic approaches for small cell lung cancer: the future has arrivedEpigenetics and autosomal dominant polycystic kidney disease.Emerging drugs for the treatment of myelodysplastic syndrome.Histone deacetylase inhibitors: insights into mechanisms of lethality.Increased Histone Deacetylase Activity Involved in the Suppressed Invasion of Cancer Cells Survived from ALA-Mediated Photodynamic Treatment.Epigenetic control of the immune escape mechanisms in malignant carcinomas.Erythropoietin-driven signalling and cell migration mediated by polyADP-ribosylation.
P2860
Q24596282-D3E48D1E-C6AC-44E0-81D0-66E09EC31294Q24650710-0C88F490-676F-46C9-8029-D8486CB511BBQ24682174-C434993E-D702-4612-A814-58443679ABA2Q26799878-AC17275A-47C1-4D24-ABE9-47E0C5075213Q27009399-605ADBDC-59A1-445E-8011-9A2140F68571Q27938515-F8A3B61E-1F3A-42A0-8B5D-D9EB200F6F20Q28300315-B1E94EED-AC36-4E5D-9E02-868C4873E3BAQ28389137-F2F517E1-8D68-47F1-9537-7CDCF2F226BDQ28484361-12725232-5E72-48C0-AEA4-CF8CED1B2AC0Q28487810-3CDD4E73-08A8-4027-AEEE-A5D19013C8FDQ28548415-1ED240EF-7BB4-4F1B-BB42-3B731AA54A26Q28550025-498319BF-C53A-4D41-800B-E19A92D90356Q28972517-BDC29F91-6F95-4898-945C-9AAF195B5B68Q33757651-B28B9089-FB6C-4BFF-AB7E-C429B0D8D77CQ33836380-CF4FBB68-8529-4BB9-8527-9B186789C241Q33860585-A405546E-8483-4396-84D5-76A41B630BFBQ33862991-D1FA34A0-8DCF-46A5-8CCC-D874127F05BDQ34095995-897CFE9E-2C2C-4BC1-B2DA-7CCA97D7AC59Q34104350-016D37F5-03DC-4ECC-9AFA-69BB584DED64Q34272080-D9D472E7-64C0-46E6-8BBD-6E92A61885C7Q34322087-21DB852B-B625-48D1-90FA-4FD2F3718FEDQ34333679-AE2407B9-894E-4B06-BD41-3DF5A2FCAC72Q34505026-93FF7481-7466-4663-ABF9-168AA2D84213Q34505719-A27E4961-4FE3-47EF-8A3B-C810E71DF6EFQ34541960-45548DAC-8D55-4E70-ABCA-4E106A9C948EQ34739990-2C10E6EA-6D98-48E8-B469-FAF65A1AB202Q34863607-C8D11868-AC01-438E-9B65-794D834CD49BQ34979322-A927C4F1-3A99-460E-B17A-EBDB4416F1BAQ35006755-CFB53AD2-B08B-4A95-8175-93BBFD0F7738Q35011880-D9C29293-8D66-487B-8916-537CB60DDEB4Q35609717-B8C49160-F4A2-46CB-B29B-154640F02553Q35836257-09A68E2D-F4C9-4ED3-9C1F-77913C90A342Q35867015-A6C67A91-5B79-4659-B4F4-4BC94A96A2A6Q36084288-4C6CD0B6-F2FF-4BC9-B912-8DC5C548AD5AQ36146066-5493200D-4ADC-4784-87D7-362DDA5FD31EQ36219655-EB79AA1E-5C80-4BF0-AB8D-12DD136010A1Q36219726-1BB96F95-5884-4BBF-B63B-E85EB550FBC1Q36247349-F7AFC31B-E9E4-48AC-825E-3D16517D8531Q36315881-AD9945A0-6234-4093-9727-D15995D8B842Q36387871-2C6E2084-002A-49A2-B951-1BF79789DA21
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Histone acetylation and chromatin remodeling.
@ast
Histone acetylation and chromatin remodeling.
@en
Histone acetylation and chromatin remodeling.
@nl
type
label
Histone acetylation and chromatin remodeling.
@ast
Histone acetylation and chromatin remodeling.
@en
Histone acetylation and chromatin remodeling.
@nl
prefLabel
Histone acetylation and chromatin remodeling.
@ast
Histone acetylation and chromatin remodeling.
@en
Histone acetylation and chromatin remodeling.
@nl
P2093
P356
P1476
Histone acetylation and chromatin remodeling.
@en
P2093
P304
P356
10.1006/EXCR.2001.5187
P407
P577
2001-05-01T00:00:00Z